Back to Search
Start Over
Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study.
- Source :
- Gynecological Endocrinology; May2020, Vol. 36 Issue 5, p421-425, 5p
- Publication Year :
- 2020
-
Abstract
- <i>Copyright of Gynecological Endocrinology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- TYPE 2 diabetes
OSTEOPOROSIS in women
METFORMIN
CELLULAR aging
PHARMACOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 09513590
- Volume :
- 36
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Gynecological Endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 143139260
- Full Text :
- https://doi.org/10.1080/09513590.2020.1718092